Alex joined CIT in 2011 and is responsible for deal sourcing, due diligence and closing seed and early stage investments. Prior to CIT, Alex was the Director of the Advantage Incubator at bwtech@UMBC and program manager for the Northrop Grumman Cync Program where, in addition to identifying and recruiting innovative cybersecurity companies for the program, he provided business mentorship and capital access services to entrepreneurs and worked to cultivate strategic relationships with various stakeholders, including investors. Prior to managing the incubator program, Alex spent several years at MdBio - one of the largest biotechnology trade associations in the nation, where he led a number of initiatives designed to assist nearly 300+ emerging bioscience member companies. Alex has also been involved with several start-ups over the years in both the life sciences and social media as either an early employee or co-founder. Alex holds a BS in Biochemistry and Molecular Biology from UMBC, studied biotechnology at Johns Hopkins University and the University of Maryland, and is an MBA candidate at the F.W. Olin Graduate School of Business at Babson College. He has been an author on several scientific papers in a diversity of areas from molecular biology to physical chemistry and spectroscopy.

Featuring

• 

  Panel: Funding the Next Medical Breakthrough